TOKYO -- Japan looks to begin distribution of COVID-19 vaccines by the March end of the fiscal year as clinical trials on a number of candidates move forward.
Fast-track approval an option for Pfizer, AstraZeneca or Moderna jabs
TOKYO -- Japan looks to begin distribution of COVID-19 vaccines by the March end of the fiscal year as clinical trials on a number of candidates move forward.